Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Akoya Biosciences Inc (NQ: AKYA ) 2.340 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 2.340 Bid (Size) 2.200 (12) Ask (Size) 2.390 (1) Prev. Close 2.340 Today's Range 2.340 - 2.340 52wk Range 1.880 - 7.680 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Analyst Scoreboard: 4 Ratings For Akoya Biosciences June 03, 2024 Via Benzinga Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 14, 2024 Via Benzinga Performance YTD -51.05% -51.05% 1 Month +8.84% +8.84% 3 Month -48.68% -48.68% 6 Month -51.05% -51.05% 1 Year -66.23% -66.23% More News Read More 12 Health Care Stocks Moving In Tuesday's Intraday Session May 14, 2024 Via Benzinga Recap: Akoya Biosciences Q4 Earnings March 04, 2024 Via Benzinga Earnings Outlook For Akoya Biosciences March 01, 2024 Via Benzinga Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket May 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 14, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 14, 2024 Via InvestorPlace AKYA Stock Earnings: Akoya Biosciences Misses EPS, Misses Revenue for Q1 2024 May 13, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session May 13, 2024 Via Benzinga Akoya Biosciences Reports First Quarter 2024 Financial Results May 13, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients May 09, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts May 06, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows May 02, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024 April 22, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale April 05, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023 March 04, 2024 Via InvestorPlace Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook March 04, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Earnings Scheduled For March 4, 2024 March 04, 2024 Via Benzinga Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference February 08, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases January 18, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board January 10, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow January 07, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform January 07, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook January 07, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
